Gleevec and Avonex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gleevec (imatinib mesylate) and Avonex (interferon beta 1a). Common drug interactions include fall among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Gleevec and Avonex. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Gleevec?

Gleevec has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 35,415 Gleevec users. Check the latest studies of Gleevec.

What is Avonex?

Avonex has active ingredients of interferon beta 1a. It is often used in multiple sclerosis. eHealthMe is studying from 198,544 Avonex users. Check the latest studies of Avonex.

On Jul, 15, 2026

11 people who take Gleevec and Avonex together, and have interactions are studied.

What are the common drug interactions of Gleevec and Avonex, by gender? *:

female:

Fall
Gait disturbance
Hemiparesis (weakness on one side of the body)
Benign breast neoplasm (benign (non-cancerous) tumours of the breast)
Cardiac failure congestive
Cerebral infarction (less blood supply to brain resulting tissue damage)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
Eye disorder
General symptom

male:

Fatigue (feeling of tiredness)
Muscular weakness (muscle weakness)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Optic neuritis (optic nerve inflammation)
Fall
Visual impairment
Abasia (inability to walk)
Abdominal pain upper
Death
Delusion (a false belief or opinion)

What are the common drug interactions of Gleevec and Avonex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Bipolar disorder (mood disorder)
Essential hypertension (primary hypertension)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Gastrointestinal stromal tumour (a cancer that arises from transformed cells of mesenchymal origin in gastrointestinal tract)
Hypercholesterolaemia (high levels of cholesterol in the blood)

60+:

Fall
Hemiparesis (weakness on one side of the body)
Diarrhoea
Epistaxis (bleed from the nose)
Erythema (redness of the skin)
Face injury
Gait disturbance
Gastrointestinal injury (injury to gastrointestinal tract)
Hand fracture
Injection site pain

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 27.27%
Gastrointestinal Stromal Tumor: 2 people, 18.18%
Leukaemia (blood or bone marrow cancer): 1 person, 9.09%
Hepatic Cancer Metastatic (liver cancer - metastatic): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Gleevec and Avonex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously